Page last updated: 2024-11-07

methylmercury cysteine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

methylmercury cysteine: degradation product of methylmercury glutathione; RN given refers to (L-cysteinato)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID151723
SCHEMBL ID3397998
MeSH IDM0096636

Synonyms (7)

Synonym
methylmercuric cysteine
methylmercury cysteine
12628-19-2
SCHEMBL3397998
mercury, (l-cysteinato)methyl-
(2r)-2-amino-3-sulfanylpropanoate;methylmercury(1+)
DTXSID501047769

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Exogenous compounds including drugs and toxic substances occurring in the environment pass through the transporters with broad substrate selectivity, namely "multispecific" transporters, taking advantage of the multispecific nature to exert their toxic effects."( Functional properties of multispecific amino acid transporters and their implications to transporter-mediated toxicity.
Endou, H; Kanai, Y, 2003
)
0.32
" Therefore, the purpose of the current study was to assess the transport of MeHg into placental syncytiotrophoblasts and to characterize the mechanisms by which MeHg exerts its toxic effects."( Transport and Toxicity of Methylmercury-Cysteine in Cultured BeWo Cells.
Barkin, JL; Bridges, CC; Farrell, ER; Ford, EG; Ganapathy, S; Joshee, L; McKallip, RJ; Uchakina, O; Vaghela, S, 2021
)
0.62

Pharmacokinetics

ExcerptReferenceRelevance
" When rats received it intravenously, MeHg·Cl showed 20-fold greater plasma and 2-fold greater blood concentrations of Hg than MeHg-Cys, indicating that their pharmacokinetic properties are different."( Comparison of in vivo with in vitro pharmacokinetics of mercury between methylmercury chloride and methylmercury cysteine using rats and Caco2 cells.
Matsumura, N; Mori, N; Murakami, T; Sasaki, M; Tsukada, E; Yamamoto, M; Yokooji, T, 2012
)
0.6

Bioavailability

ExcerptReferenceRelevance
" To date there are very few studies on the effects of speciation and bioavailability of MeHg in these organisms, and even fewer studies on the role that binding to cellular ligands plays on MeHg uptake."( The effect of aqueous speciation and cellular ligand binding on the biotransformation and bioavailability of methylmercury in mercury-resistant bacteria.
Barkay, T; Mason, RP; Ndu, U; Reinfelder, JR; Schartup, AT, 2016
)
0.43

Dosage Studied

ExcerptRelevanceReference
" Yet dosing studies are generally carried out using methylmercury chloride."( Form of Dietary Methylmercury does not Affect Total Mercury Accumulation in the Tissues of Zebra Finch.
Cristol, DA; Rice, GW; Varian-Ramos, CW; Whitney, M, 2017
)
0.46
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
L-alpha-amino acid zwitterionZwitterionic form of an L-alpha-amino acid having an anionic carboxy group and a protonated amino group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (24)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (4.17)18.7374
1990's1 (4.17)18.2507
2000's12 (50.00)29.6817
2010's9 (37.50)24.3611
2020's1 (4.17)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 17.53

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index17.53 (24.57)
Research Supply Index3.30 (2.92)
Research Growth Index5.65 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (17.53)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (3.85%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other25 (96.15%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]